Trial
NCT01268644
Effects of Metreleptin in Type 1 Diabetes Mellitus
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University of Texas Southwestern Medical Center
Collaborators
Juvenile Diabetes Research Foundation; Amylin Pharmaceuticals, LLC.
Condition
Type 1 Diabetes
Intervention
Leptin
Why stopped
Sponsor request
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-08-28